Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study. - Cayla S; Karlin L; Lambert J; Lazareth A; Talbot A; Mohty M; Malard F; Petillon MO; Manier S; Yakoub-Agha I; Caillot D; Lafon I; et al. (Blood advances, 2026)